LYRA THERAPEUTICS, INC. EIGHTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTPurchase Agreement • March 6th, 2020 • Lyra Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
This Agreement dated as of January 10, 2020 is entered into by and among Lyra Therapeutics, Inc., a Delaware corporation (the “Company”), Carmichael Roberts, George Whitesides and Robert Langer (individually, a “Founder” and collectively, the “Founders”) and the individuals and entities listed as preferred stockholders on Schedule A attached hereto (individually, an “Investor” and collectively, the “Investors”).
